Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 20 November 1998:
Vol. 282. no. 5393, p. 1423
DOI: 10.1126/science.282.5393.1423
Prev | Table of Contents | Next

Policy Forum

BIOLOGICAL WARFARE:
Strengthening the Biological Weapons Convention

Thomas P. Monath and Lance K. Gordon

An international treaty banning the development of biological weapons has been in effect since 1975 but lacks an effective compliance protocol for visits and inspections of facilities that might be engaged in these activities. The U.S. biopharmaceutical industry has been reluctant to subject itself to such visits. We believe that it is far more important to strengthen the treaty than to create hypothetical barriers to a compliance regime.

The authors are officers of OraVax Incorporated, Cambridge, MA 02139, USA. E-mail: tmonath{at}oravax.com

Read the Full Text

To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)